"Designing Growth Strategies is in our DNA"

Biomarkers Validation and Testing Market Size, Share & Industry Analysis, By Technique (Biomarker Immunoassays, Flow Cytometry, Others), By Applications (Oncology, Drug Discovery & Development, Others), By End-user (Pharmaceutical & Biotechnology Companies, Research Institutes & CRO’s, Others) And Regional Forecast 2021-2028

Region : Global | Report ID: FBI105042 | Status : Ongoing

 

KEY MARKET INSIGHTS

Biomarkers are used in all areas of medicine to predict, diagnose, characterize, or to treat a disease. A biomarker represents a biological molecule that is used efficiently and precisely to evaluate pharmacologic responses.  Biomarker testing is used prominently in drug discovery and treatment of cancer. Validation of a biomarker is essential in delivery of high-quality research data necessary for effective use of biomarkers.  Once a biomarker is validated, it is then used in drug development for disease identification or disease treatment. NeoGenomics, Inc. in 2017 announced the expansion of Immuno-Oncology profiling tests that includes microsatellite instability (MSI) testing and tumor mutation burden (TMB).


Increasing prevalence of the chronic diseases is leading to higher demand for the biomarkers. This factor is responsible for driving the growth of the global biomarkers validation and testing market. Additionally, increased investment in the drug discovery and development and high input in the research activities on the development of the diagnostics markers are some of the major factors driving the growth of the global biomarkers validation and testing market.


However, numerous challenges faced by pharmaceutical company researchers in biomarker validation and testing is the factor restraining the growth of the global biomarkers validation and testing market. In addition, high-cost of biomarker validation immuno-assays is likely to have negative impact on the growth of the global market.


Key Market Driver -

Increasing R&D for drug discovery and development

Key Market Restraint -

Challenges faced in biomarker validation and testing


Market Segmentation:


By technique, the market is segmented into biomarker immunoassays, flow cytometry and others. Based on applications, the market is segmented into oncology, drug discovery & development and others. Based on end-users, the Biomarkers Validation and Testing Market is segmented into pharmaceutical & biotechnology companies, research institutes & CRO’s and others.


From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.


Key Players Covered:


The major companies in the global biomarkers validation and testing market report include LGC Limited, SGS SA, BiomarkerBay B. V, Intertek Group plc, Eurofins Central Laboratory, AnyGenes, NeoGenomics Laboratories, Inc., GP-Bio Inc, Covance Inc., and others.


Key Insights:



  • Overview of Regulatory Scenario in the Biomarker Validation and Testing Market

  • Technological Advancements in the Biomarker Validation and Testing Market

  • Key Mergers and Acquisitions


Regional Analysis:


Geographically the global biomarker validation and testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among the regions, North America accounted for the largest share of the global biomarkers validation and testing market in 2018. The leading position is attributable to the high investments in research and development of the biomarkers, increasing prevalence of cancer, and adoption of personalized medicine by patient pool. Asia Pacific region is anticipated grow at a higher CAGR owing to rise in cancer diagnostic test by patients, need for accurate diagnostics and validation of assays for drug development and discovery as well as strong government backup and funding to launch novel drugs in the market. Latin America and Middle East & Africa are expected to have slower market growth owing to less R&D investments and lack of awareness for technological advancements.


To gain extensive insights into the market, Request for Customization


Segmentation


























  ATTRIBUTE


  DETAILS

By Technique




  • Biomarker Immunoassays

  • Flow Cytometry

  • Others



By Applications




  • Oncology

  • Drug Discovery & Development

  • Others



By End-user




  • Pharmaceutical & Biotechnology Companies

  • Research Institutes & CRO’s

  • Others



By Geography




  • c



Biomarker Validation and Testing Industry Developments



  • In November 2019, Biocept Inc. launched a liquid biopsy test TARGET SELECTOR, a pan-TRK assay for the detection of TRK proteins designed to provide physicians with presence of NTRK fusions in patients diagnosed with cancer.

  • In October 2019, Biocartis Group NV announced the launch of IDYLLA ctEGFR Mutation Assay. The liquid biopsy assay provides accurate and highly molecular information of 49 EGFR mutations from blood plasma of a cancer patient.

  • In May 2019, Roche launched VENTANA HER2 Dual ISH DNA Probe Cocktail assay, to detect HER2 biomarker found in the breast and gastric cancers.

  • In May 2019, QIAGEN announced the launch of therascreen PIK3CA RGQ PCR Kit. The USFDA approved kit is useful in detection of activating mutations of PIK3CA gene in any cancer indications.


Biomarkers Validation and Testing Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Roche
Styker
iqvia
Amgen
abbvie

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X